Smoking cessation drug approved by the FDA
May 30th, 2006 by Nina Thompson, ARNP
The U.S. Food and Drug Administration (FDA) has approved Chantix (varenicline tartrate) to help cigarette smokers stop smoking. Chantix is an oral tablet to be taken twice daily for 12 weeks. It will be available by prescription only and is not recommended for children under 18 years of age.
The active ingredient in Chantix, varenicline tartrate, acts at sites in the brain affected by nicotine and may help those who wish to give up smoking in two ways: by providing some nicotine effects to ease the withdrawal symptoms and by blocking the effects of nicotine from cigarettes if they resume smoking.
via FDA, May 2006
Bookmark this page
E-mail this story
Print this post
0 Responses to “Smoking cessation drug approved by the FDA”